ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1710

Musculoskeletal Symptoms Preceding the Diagnosis of Psoriatic Arthritis – a Qualitative Exploration of the Patient Journey

Nigara Rasappu1, Kim Wervers2, Ilja Tchetverikov3, Marc R. Kok4, Andreas H. Gerards5, Marijn Vis1 and Jolanda J. Luime1, 1Rheumatology, Erasmus Medical Centre, Rotterdam, Netherlands, 2Erasmus Medical Centre, Rotterdam, Netherlands, 3Albert Schweitzer Hospital, Dordrecht, Netherlands, 4Rheumatology, Maasstad Hospital, Rotterdam, Netherlands, 5Rheumatology, Vlietland Hospital, Schiedam, Netherlands

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Psoriatic arthritis and qualitative

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2016

Title: Spondylarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment - Poster II: Psoriatic Arthritis

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Given the difficulties non-rheumatologists experience to early refer psoriasis patients at risk for Psoriatic Arthritis (PsA) we aim to explore patients experience of musculoskeletal symptoms and understand patients’ self-management of symptoms preceding the diagnosis of PsA through a qualitative study to provide a state of the art view on current medical practice eliciting room to improve early detection of PsA.

 

Methods:

A semi structured interview was developed based on the available literature and informal conversations with patients. The following data was collected from newly diagnosed PsA patients participating in the Dutch south wEst Psoriatic ARthritis cohort (DEPAR): medical history, physical load, previous and current joint and tendon complaints, general complaints, disabilities and emotional status and its influence on their daily life.  

Results:

24 Newly diagnosed PsA patients (median age 52; 54% male; median duration of symptoms four years; 17% mono-, 21% oligo, 29% poly arthritis, 25% dactylitis, 4% axial and 8% enthesitis) participated in this study.

 

Patient at first did not involve their GP as they attributed their symptoms to physical exertion, obesity or other morbidity. If symptoms continued or worsened they involved their GP. Symptoms of the shoulders, wrists, back, hips and knees were first referred to physiotherapist or other specialists before they were seen by a rheumatologist, often taking years. While patients with hand symptoms were referred to the rheumatologist more quickly, as were patients with rapid accumulation of complaints.

 

Figure 1 shows the different ways patients dealt with their symptoms before visiting the GP. Patients experience pain, stiffness, loss of strength and fatigue. Some patients decide to proceed with physical activity which often resulted in more pain and inability to perform daily activities. Some choose to avoid all physical activities that causes pain. And others choose to pace their activities. Ultimately, most of our patients ended up choosing for the latter. However, all patients experienced disability which often resulted in stress, frustration, sadness or anger.

 

 

 

Conclusion:

Patients and physicians are not alerted that symptoms of the large joints may be underlying PsA. Patients often first see physiotherapist and other specialist before they finally arrive at the rheumatologist. In the period preceding the diagnosis all patients struggle with pain and other symptoms impacting their daily life. Initially, they choose different coping strategies. While over time they all choose to pace their activities at the cost of losing wellbeing.  


Disclosure: N. Rasappu, None; K. Wervers, None; I. Tchetverikov, None; M. R. Kok, None; A. H. Gerards, None; M. Vis, None; J. J. Luime, None.

To cite this abstract in AMA style:

Rasappu N, Wervers K, Tchetverikov I, Kok MR, Gerards AH, Vis M, Luime JJ. Musculoskeletal Symptoms Preceding the Diagnosis of Psoriatic Arthritis – a Qualitative Exploration of the Patient Journey [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/musculoskeletal-symptoms-preceding-the-diagnosis-of-psoriatic-arthritis-a-qualitative-exploration-of-the-patient-journey/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/musculoskeletal-symptoms-preceding-the-diagnosis-of-psoriatic-arthritis-a-qualitative-exploration-of-the-patient-journey/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology